Adagene Inc. (ADAG)
NASDAQ: ADAG · IEX Real-Time Price · USD
1.93
+0.15 (8.51%)
At close: Dec 29, 2023, 4:00 PM
1.87
-0.06 (-3.18%)
After-hours: Dec 29, 2023, 4:17 PM EST
Adagene Market Cap
Adagene has a market cap or net worth of $80.62 million as of December 29, 2023. Its market cap has increased by 54.75% in one year.
Market Cap
80.62M
Enterprise Value
-22.90M
1-Year Change
54.75%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $80.62M, a decrease of -89.97%. That is a compound annual growth rate of -54.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 83.50M | 12.23% |
Dec 28, 2023 | 74.40M | 3.62% |
Dec 27, 2023 | 71.80M | -0.55% |
Dec 26, 2023 | 72.20M | -0.69% |
Dec 22, 2023 | 72.70M | -0.55% |
Dec 21, 2023 | 73.10M | -6.16% |
Dec 20, 2023 | 77.90M | 21.72% |
Dec 19, 2023 | 64.00M | 0.95% |
Dec 18, 2023 | 63.40M | -4.23% |
Dec 15, 2023 | 66.20M | -9.44% |
Dec 14, 2023 | 73.10M | -3.43% |
Dec 13, 2023 | 75.70M | -2.82% |
Dec 12, 2023 | 77.90M | -0.13% |
Dec 11, 2023 | 78.00M | -4.06% |
Dec 8, 2023 | 81.30M | 4.36% |
Dec 7, 2023 | 77.90M | -6.14% |
Dec 6, 2023 | 83.00M | 14.17% |
Dec 5, 2023 | 72.70M | 4.01% |
Dec 4, 2023 | 69.90M | 6.39% |
Dec 1, 2023 | 65.70M | -13.21% |
Nov 30, 2023 | 75.70M | 19.03% |
Nov 29, 2023 | 63.60M | 0.79% |
Nov 28, 2023 | 63.10M | 1.28% |
Nov 27, 2023 | 62.30M | - |
Nov 24, 2023 | 62.30M | 0.65% |
View and export this data all the way back to 2021.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Champions Oncology | 73.54M |
Cidara Therapeutics | 73.25M |
CollPlant Biotechnologies | 73.07M |
Clearside Biomedical | 73.02M |
Kronos Bio | 72.31M |
Cutera | 71.80M |
Vicarious Surgical | 71.53M |
GeneDx Holdings | 71.44M |